2023
DOI: 10.1002/1873-3468.14719
|View full text |Cite
|
Sign up to set email alerts
|

Autophagy as a caretaker of nuclear integrity

Emily Boyle,
Florian Wilfling

Abstract: Due to their essential functions, dysregulation of nuclear pore complexes (NPCs) is strongly associated with numerous human diseases, including neurodegeneration and cancer[1]. On a cellular level, longevity of scaffold nucleoporins in post‐mitotic cells of both C. elegans and mammals renders them vulnerable to age‐related damage, which is associated with an increase in pore leakiness and accumulation of intranuclear aggregates in rat brain cells[2–4]. Thus, understanding the mechanisms which underpin the home… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 93 publications
0
1
0
Order By: Relevance
“…Each nuclear pore complex is composed of a total of 500-1000 nucleoporins, the proteins that build NPCs, among which over 30 are present in multiple copies, thanks to the eight-fold symmetry of the structure [1][2][3][4][5]. In this collection, NPC quality control mechanisms are discussed by Penzo and Palancade [6], Boyle and Wilfling [7], and Veldsink et al [8]. These articles focus not only on NPC assembly per se, but Birthe Fahrenkrog is a Senior Research Fellow at the Biozentrum, University of Basel, Switzerland.…”
mentioning
confidence: 99%
“…Each nuclear pore complex is composed of a total of 500-1000 nucleoporins, the proteins that build NPCs, among which over 30 are present in multiple copies, thanks to the eight-fold symmetry of the structure [1][2][3][4][5]. In this collection, NPC quality control mechanisms are discussed by Penzo and Palancade [6], Boyle and Wilfling [7], and Veldsink et al [8]. These articles focus not only on NPC assembly per se, but Birthe Fahrenkrog is a Senior Research Fellow at the Biozentrum, University of Basel, Switzerland.…”
mentioning
confidence: 99%